Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
BMJ Open Gastroenterology, vol. 7, pp. e000468
Abstract
OBJECTIVE: infection (CDI) is a common healthcare-associated infection and associated with high morbidity and mortality. As current guidelines recommend treatment stratified for disease severity, this study aimed to identify predictors of 30-day mortality in order to develop a robust prediction model. DESIGN: This was a retrospective analysis of 207 inpatients with CDI who were treated at the Jena University Hospital between September 2011 and December 2015. In a training cohort (n=127), predictors of 30-day mortality were identified by receiver operating characteristics analysis and logistic regression. The derived model was validated in an independent cohort of 80 inpatients with CDI. RESULTS: Within 30 days, 35 (28%) patients in the training cohort died from any cause. C-reactive protein (CRP) of ≥121 mg/L (OR 3.80; 95% CI 1.64 to 7.80; p=0.003) and lower systolic blood pressure of ≤104 mm Hg (OR 3.73; 95% CI 1.63 to 8.53; p=0.002) at diagnosis as well as development of renal impairment (serum creatinine >1.5×baseline; OR 5.61; 95% CI 1.94 to 16.26; p=0.035) within the first 6 days were associated with 30-day mortality in univariate analysis. The use of these parameters enabled correct mortality prediction in 73% of cases on the day of diagnosis and in 76% at day 6. In the validation cohort, 30-day mortality was 18/80 (23%). Our model enabled a 73.7% correct prediction concerning 30-day mortality on day 6 after diagnosis of CDI. CONCLUSION: Hypotension and CRP elevation on the day of diagnosis as well as occurrence of kidney dysfunction during the first 6 days are suitable parameters to predict 30-day mortality in patients with CDI who need to be treated in the hospital.
Authors 5
-
Katrin Katzer corresponding
Affiliation as printed
Department of Internal Medicine IV, Jena University Hospital, Jena, Germany
-
Affiliation as printed
Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
-
Affiliation as printed
Department of Internal Medicine IV, Jena University Hospital, Jena, Germany
-
RWTH Aachen University · Jena University Hospital
Affiliation as printed
Department of Internal Medicine IV, Jena University Hospital, Jena, Germany
Medical Department III, RWTH Aachen University, Aachen, Nordrhein-Westfalen, Germany
-
Affiliation as printed
Department of Internal Medicine IV, Jena University Hospital, Jena, Germany
Cited by 8 stored of 8
8 results
No patents citing this paper on Lens.org (checked 2026-10-06).
References 36
-
W1447391314details pending0citations
-
W1538976876details pending0citations
-
W1559039796details pending0citations
-
W1874478037details pending0citations
-
W1916481354details pending0citations
-
W1968205721details pending0citations
-
W1969144992details pending0citations
-
W1992127020details pending0citations
-
W2030116611details pending0citations
-
W2041040328details pending0citations
-
W2055043960details pending0citations
-
W2088752394details pending0citations
-
W2101963923details pending0citations
-
W2107698684details pending0citations
-
W2113556993details pending0citations
-
W2126927211details pending0citations
-
W2134665827details pending0citations
-
W2135959117details pending0citations
-
W2136245438details pending0citations